MLTX vs REGN: Which Stock is Better?
Side-by-side comparison of MoonLake Immunotherapeutics and Regeneron Pharmaceuticals Inc in 2026
MLTX
MoonLake Immunotherapeutics
—
REGN
Regeneron Pharmaceuticals Inc
$635.45
Key Metrics Comparison
| Metric | MLTX | REGN | Winner |
|---|---|---|---|
| Market Cap | $1.38B | $59.10B | REGN |
| P/E Ratio | N/A | 13.91 | REGN |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze MLTX
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is MLTX or REGN a better investment?
Comparing MLTX and REGN: MoonLake Immunotherapeutics has a market cap of $1.38B while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between MLTX and REGN?
MLTX (MoonLake Immunotherapeutics) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: MLTX or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: MLTX or REGN?
Both MLTX and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: MLTX or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: MLTX or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $1.38B for MLTX.
Should I buy MLTX or REGN in 2026?
Both MLTX and REGN have investment merit. MLTX trades at $N/A while REGN trades at $635.45. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between MLTX and REGN stock?
Key differences: Market Cap ($1.38B vs $59.10B), P/E Ratio (N/A vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy MLTX or REGN in 2026?
The choice between MLTX and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between MLTX and REGN?
MLTX (MoonLake Immunotherapeutics) has a market cap of $1.38B, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.